A Phase IIa Study of NT-KO-003 for Multiple Sclerosis

Clinical trial NCT01428726 · COMPLETED

Trial details

NCT number: NCT01428726
Sponsor: Neurotec Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Remitting Multiple Sclerosis

Start date: 2011-06-01
Primary completion: 2014-01-01
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.